776
Views
19
CrossRef citations to date
0
Altmetric
Review Article

The use of ketamine in ECT anaesthesia: A systematic review and critical commentary on efficacy, cognitive, safety and seizure outcomes

, &
Pages 424-444 | Received 05 Jun 2016, Accepted 17 Oct 2016, Published online: 28 Nov 2016

References

  • Abdallah CG, Fasula M, Kelmendi B, Sanacora G, Ostroff R. 2012. Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting. J ECT. 28:157–161.
  • Abrams R. 2002. Electroconvulsive Therapy. 4th ed. New York: Oxford University Press.
  • Alison McInnes L, James-Myers MB, Turner MS. 2016. Possible affective switch associated with intravenous ketamine treatment in a patient with bipolar I disorder. Biol Psychiatry. 79:e71–e72.
  • Alizadeh NSMA, Nasseri K, Najafabadi SHS, Taghiabad AM, Gharibi F, Esfandiari GR. 2015. Antidepressant effect of combined ketamine and electroconvulsive therapy on patients with major depressive disorder: a randomized trial. Iran J Psychiatry Behav Sci. 9:e1578.
  • Banwari G, Desai P, Patidar P. 2015. Ketamine-induced affective switch in a patient with treatment-resistant depression. Indian J Pharmacol. 47:454–455.
  • Bauer J, Hageman I, Dam H, Baez A, Bolwig T, Roed J, Olsen NV, Jorgensen MB. 2009. Comparison of propofol and thiopental as anesthetic agents for electroconvulsive therapy: a randomized, blinded comparison of seizure duration, stimulus charge, clinical effect, and cognitive side effects. J ECT. 25:85–90.
  • Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP. 1998. Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations. Anesthesiology. 88:82–88.
  • Boylan LS, Haskett RF, Mulsant BH, Greenberg RM, Prudic J, Spicknall K, Lisanby SH, Sackeim HA. 2000. Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors. J ECT. 16:3–18.
  • Bundy BD, Hewer W, Andres FJ, Gass P, Sartorius A. 2010. Influence of anesthetic drugs and concurrent psychiatric medication on seizure adequacy during electroconvulsive therapy. J Clin Psychiatry. 71:775–777.
  • Coffey CE, Fochtmann LJ, Greenberg RM, Isenberg KE, Kellner CH, Moench LA, Sackeim HA, Weiner RD, American Psychiatric Association Committee on Electroconvulsive Therapy. 2001. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging: a task force report of the American Psychiatric Association. 2nd ed. Washington DC: American Psychiatric Association.
  • Devanand DP, Briscoe KM, Sackeim HA. 1989. Clinical features and predictors of postictal excitement. Convuls Ther. 5:140–146.
  • Domino EF. 2010. Taming the ketamine tiger. 1965. Anesthesiology. 113:678–684.
  • Erdil F, Begec Z, Kayhan GE, Yologlu S, Ersoy MO, Durmus M. 2015a. Effects of sevoflurane or ketamine on the QTc interval during electroconvulsive therapy. J Anesth. 29:180–185.
  • Erdil F, Ozgul U, Colak C, Cumurcu B, Durmus M. 2015b. Effect of the addition of ketamine to sevoflurane anesthesia on seizure duration in electroconvulsive therapy. J ECT. 31:182–185.
  • Erdogan Kayhan G, Yucel A, Colak YZ, Ozgul U, Yologlu S, Karlidag R, Ersoy MO. 2012. Ketofol (mixture of ketamine and propofol) administration in electroconvulsive therapy. Anaesth Intensive Care. 40:305–310.
  • Folkerts H. 1996. The ictal electroencephalogram as a marker for the efficacy of electroconvulsive therapy. Eur Arch Psychiatry Clin Neurosci. 246:155–164.
  • Fond G, Loundou A, Rabu C, Macgregor A, Lancon C, Brittner M, Micoulaud-Franchi JA, Richieri R, Courtet P, Abbar M, et al. 2014. Ketamine administration in depressive disorders: a systematic review and meta-analysis. Psychopharmacology (Berl). 231:3663–3676.
  • Fond G, Bennabi D, Haffen E, Brunel L, Micoulaud-Franchi JA, Loundou A, Lançon C, Llorca PM, Auquier P, Boyer L. 2016. A Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness/tolerability profile in electroconvulsive therapy for major depression. Sci Rep. 6:19847.
  • Gálvez V, Hadzi-Pavlovic D, Smith D, Loo CK. 2015a. Predictors of seizure threshold in right unilateral ultrabrief electroconvulsive therapy: role of concomitant medications and anaesthesia used. Brain Stimul. 8:486–492.
  • Gálvez V, Hadzi-Pavlovic D, Wark H, Harper S, Leyden J, Loo CK. 2016a. The anaesthetic-ECT time interval in electroconvulsive therapy practice-is it time to time? Brain Stimul. 9:72–77.
  • Gálvez V, Ho KA, Alonzo A, Martin D, George D, Loo CK. 2015b. Neuromodulation therapies for geriatric depression. Curr Psychiatry Rep. 17:59.
  • Gálvez V, Tor PC, Bassa A, Hadzi-Pavlovic D, MacPherson R, Marroquin-Harris M, Loo CK. 2016b. Does remifentanil improve ECT seizure quality? Eur Arch Psychiatry Clin Neurosci. 266:719–724.
  • Ghasemi M, Kazemi MH, Yoosefi A, Ghasemi A, Paragomi P, Amini H, Afzali MH. 2014. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder. Psychiatry Res. 215:355–361.
  • Gregory-Roberts EM, Naismith SL, Cullen KM, Hickie IB. 2010. Electroconvulsive therapy-induced persistent retrograde amnesia: could it be minimised by ketamine or other pharmacological approaches? J Affect Disord. 126:39–45.
  • Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56–62.
  • Hartvig P, Valtysson J, Lindner KJ, Kristensen J, Karlsten R, Gustafsson LL, Persson J, Svensson JO, Oye I, Antoni G, et al. 1995. Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers. Clin Pharmacol Ther. 58:165–173.
  • Hoyer C, Kranaster L, Janke C, Sartorius A. 2014. Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci. 264:255–261.
  • Ingram A, Schweitzer I, Ng CH, Saling MM, Savage G. 2007. A comparison of propofol and thiopentone use in electroconvulsive therapy: cognitive and efficacy effects. J ECT. 23:158–162.
  • Jarventausta K, Chrapek W, Kampman O, Tuohimaa K, Bjorkqvist M, Hakkinen H, Yli-Hankala A, Leinonen E. 2013. Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot study. J ECT. 29:158–161.
  • Katalinic N, Lai R, Somogyi A, Mitchell PB, Glue P, Loo CK. 2013. Ketamine as a new treatment for depression: a review of its efficacy and adverse effects. Aust NZ J Psychiatry. 47:710–727.
  • Kellner CH, Knapp R, Husain MM, Rasmussen K, Sampson S, Cullum M, McClintock SM, Tobias KG, Martino C, Mueller M, et al. 2010. Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial. Br J Psychiatry. 196:226–234.
  • Kikuchi A, Yasui-Furukori N, Fujii A, Katagai H, Kaneko S. 2009. Identification of predictors of post-ictal delirium after electroconvulsive therapy. Psychiatry Clin Neurosci. 63:180–185.
  • Kranaster L, Kammerer-Ciernioch J, Hoyer C, Sartorius A. 2011. Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci. 261:575–582.
  • Krystal AD, Coffey CE, Weiner RD, Holsinger T. 1998. Changes in seizure threshold over the course of electroconvulsive therapy affect therapeutic response and are detected by ictal EEG ratings. J Neuropsychiatry Clin Neurosci. 10:178–186.
  • Krystal AD, Weiner RD. 1994. ECT seizure therapeutic adequacy. Convuls Ther. 10:153–164.
  • Krystal AD, Weiner RD, Coffey CE. 1995. The ictal EEG as a marker of adequate stimulus intensity with unilateral ECT. J Neuropsychiatry Clin Neurosci. 7:295–303.
  • Krystal AD, Weiner RD, Coffey CE, McCall WV. 1996a. Effect of ECT treatment number on the ictal EEG. Psychiatry Res. 62:179–189.
  • Krystal AD, Weiner RD, Dean MD, Lindahl VH, Tramontozzi LA, 3rd., Falcone G, Coffey CE. 2003. Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. J Neuropsychiatry Clin Neurosci. 15:27–34.
  • Krystal AD, Weiner RD, Gassert D, McCall WV, Coffey CE, Sibert T, Holsinger T. 1996b. The relative ability of three ictal EEG frequency bands to differentiate ECT seizures on the basis of electrode placement, stimulus intensity, and therapeutic response. Convuls Ther. 12:13–24.
  • Kuşçu ÖÖ, Karacaer F, Biricik E, Güleç E, Tamam L, Güneş Y. 2015. Effect of ketamine, thiopental and ketamine-thiopental combination during electroconvulsive therapy for depression. Turk J Anaesthesiol Reanim. 43:313–317.
  • Lai R, Katalinic N, Glue P, Somogyi AA, Mitchell PB, Leyden J, Harper S, Loo CK. 2014. Pilot dose-response trial of i.v. ketamine in treatment-resistant depression. World J Biol Psychiatry. 15:579–584.
  • Lane RD, Zeitlin SB, Abrams R, Swartz CM. 1989. Differential effects of right unilateral and bilateral ECT on heart rate. Am J Psychiatry. 146:1041–1043.
  • Lerer B, Shapira B, Calev A, Tubi N, Drexler H, Kindler S, Lidsky D, Schwartz JE. 1995. Antidepressant and cognitive effects of twice- versus three-times-weekly ECT. Am J Psychiatry. 152:564–570.
  • Livingston A, Waterman AE. 1978. The development of tolerance to ketamine in rats and the significance of hepatic metabolism. Br J Pharmacol. 64:63–69.
  • Loo CK, Gálvez V, O'Keefe E, Mitchell PB, Hadzi-Pavlovic D, Leyden J, Harper S, Somogyi AA, Lai R, Weickert CS, et al. 2016. Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression. Acta Psychiatr Scand. 134:48–56. doi: 10.1111/acps.12572.
  • Loo CK, Garfield JB, Katalinic N, Schweitzer I, Hadzi-Pavlovic D. 2013. Speed of response in ultrabrief and brief pulse width right unilateral ECT. Int J Neuropsychopharmacol. 16:755–761.
  • Loo CK, Katalinic N, Garfield JB, Sainsbury K, Hadzi-Pavlovic D, Mac-Pherson R. 2012a. Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial. J Affect Disord. 142:233–240.
  • Loo CK, Katalinic N, Martin D, Schweitzer I. 2012b. A review of ultrabrief pulse width electroconvulsive therapy. Ther Adv Chronic Dis. 3:69–85.
  • Loo C, Katalinic N, Mitchell PB, Greenberg B. 2011. Physical treatments for bipolar disorder: a review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques. J Affect Disord. 132:1–13.
  • Loo CK, Katalinic N, Smith DJ, Ingram A, Dowling N, Martin D, Addison K, Hadzi-Pavlovic D, Simpson B, Schweitzer I. 2015. A randomized controlled trial of brief and ultrabrief pulse right unilateral electroconvulsive therapy. Int J Neuropsychopharmacol. 18. pii:pyu045. doi: 10.1093/ijnp/pyu045.
  • Loo CK, Sainsbury K, Sheehan P, Lyndon B. 2008. A comparison of RUL ultrabrief pulse (0.3 ms) ECT and standard RUL ECT. Int J Neuropsychopharmacol. 11:883–890.
  • Lu YY, Lin CH, Lane HY. 2016. Mania following ketamine abuse. Neuropsychiatr Dis Treat. 12:237–239.
  • Lunn RJ, Savageau MM, Beatty WW, Gerst JW, Staton RD, Brumback RA. 1981. Anesthetics and electroconvulsive therapy seizure duration: implications for therapy from a rat model. Biol Psychiatry. 16:1163–1175.
  • MacPherson RD, Loo CK. 2008. Cognitive impairment following electroconvulsive therapy-does the choice of anesthetic agent make a difference? J ECT. 24:52–56.
  • Martin DM, Gálvez V, Loo CK. 2015. Predicting retrograde autobiographical memory changes following electroconvulsive therapy: relationships between individual, treatment, and early clinical factors. Int J Neuropsychopharmacol. 18. pii:pyv067. doi: 10.1093/ijnp/pyv067.
  • Mayur PM, Gangadhar BN, Girish K, Prasad KM, Subbakrishna DK, Janakiramiah N. 1998. Acute post-ECT cardiovascular response: a comparison of threshold right unilateral and bilateral ECT. J ECT. 14:94–98.
  • McCall WV, Colenda CC, Farah BA. 1996. Ictal EEG regularity declines during a course of RUL ECT. Convuls Ther. 12:213–216.
  • McDaniel WW, Sahota AK, Vyas BV, Laguerta N, Hategan L, Oswald J. 2006. Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies. J ECT. 22:103–106.
  • McGirr A. 2015. The safety and efficacy of adjunctive ketamine in electroconvulsive therapy: response to Drs. Fond and Boyer. J Psychiatr Res. 68:283–284.
  • McGirr A, Berlim MT, Bond DJ, Neufeld NH, Chan PY, Yatham LN, Lam RW. 2015. A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability. J Psychiatr Res. 62:23–30.
  • Montgomery SA, Asberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry. 134:382–389.
  • Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J. 1993. EEG manifestations during ECT: effects of electrode placement and stimulus intensity. Biol Psychiatry. 34:321–330.
  • Okamoto N, Nakai T, Sakamoto K, Nagafusa Y, Higuchi T, Nishikawa T. 2010. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia. J ECT. 26:223–227.
  • Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, Rummans TA, O'Connor KM, Rasmussen KG, Jr., Bernstein HJ, et al. 2001. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 17:244–253.
  • Pouget P, Wattiez N, Rivaud-Pechoux S, Gaymard B. 2010. Rapid development of tolerance to sub-anaesthetic dose of ketamine: an oculomotor study in macaque monkeys. Psychopharmacology (Berl). 209:313–318.
  • Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA. 2004. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry. 55:301–312.
  • Ranjkesh F, Barekatain M, Akuchakian S. 2005. Bifrontal versus right unilateral and bitemporal electroconvulsive therapy in major depressive disorder. J ECT. 21:207–210.
  • Rasmussen KG, Jarvis MR, Zorumski CF. 1996. Ketamine anesthesia in electroconvulsive therapy. Convuls Ther. 12:217–223.
  • Rasmussen KG, Kung S, Lapid MI, Oesterle TS, Geske JR, Nuttall GA, Oliver WC, Abenstein JP. 2014. A randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapy. Psychiatry Res. 215:362–365.
  • Romeo B, Choucha W, Fossati P, Rotge JY. 2016. Time-course of depression improvement with ketamine adjunction in electroconvulsive therapy. J ECT. 32:80–81.
  • Rudolph U, Antkowiak B. 2004. Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci. 5:709–720.
  • Rybakowski JK, Bodnar A, Krzywotulski M, Chlopocka-Wozniak M, Michalak M, Rosada-Kurasinska J, Bartkowska-Sniatkowska A. 2016. Ketamine anesthesia, efficacy of electroconvulsive therapy, and cognitive functions in treatment-resistant depression. J ECT. 32:164–168.
  • Sackeim H, Decina P, Prohovnik I, Malitz S. 1987. Seizure threshold in electroconvulsive therapy. Effects of sex, age, electrode placement, and number of treatments. Arch Gen Psychiatry. 44:355–360.
  • Sackeim HA, Decina P, Malitz S, Hopkins N, Yudofsky SC, Prohovnik I. 1983. Postictal excitement following bilateral and right-unilateral ECT. Am J Psychiatry. 140:1367–1368.
  • Sackeim HA, Decina P, Portnoy S, Neeley P, Malitz S. 1987. Studies of dosage, seizure threshold, and seizure duration in ECT. Biol Psychiatry. 22:249–268.
  • Sackeim HA, Devanand DP, Prudic J. 1991. Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am. 14:803–843.
  • Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ, McElhiney MC, Coleman EA, Settembrino JM. 1993. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med. 328:839–846.
  • Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. 2007. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 32:244–254.
  • Sackeim HA, Prudic J, Nobler MS, Fitzsimons L, Lisanby SH, Payne N, Berman RM, Brakemeier EL, Perera T, Devanand DP. 2008. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimul. 1:71–83.
  • Salehi BMA, Kamali AR, Taheri-Nejad MR, Moshiri I. 2015. Impact comparison of ketamine and sodium thiopental on anesthesia during electroconvulsive therapy in major depression patients with drug-resistant; a double-blind randomized clinical trial. Ann Card Anaesth. 18:486–490.
  • Shapira B, Tubi N, Drexler H, Lidsky D, Calev A, Lerer B. 1998. Cost and benefit in the choice of ECT schedule. Twice versus three times weekly ECT. Br J Psychiatry. 172:44–48.
  • Shapira B, Tubi N, Lerer B. 2000. Balancing speed of response to ECT in major depression and adverse cognitive effects: role of treatment schedule. J ECT. 16:97–109.
  • Sobin C, Sackeim HA, Prudic J, Devanand DP, Moody BJ, McElhiney MC. 1995. Predictors of retrograde amnesia following ECT. Am J Psychiatry. 152:995–1001.
  • Stewart PT, Loo CK, MacPherson R, Hadzi-Pavlovic D. 2011. The effect of electrode placement and pulsewidth on asystole and bradycardia during the electroconvulsive therapy stimulus. Int J Neuropsychopharmacol. 14:585–594.
  • Tor PC, Bautovich A, Wang MJ, Martin D, Harvey SB, Loo C. 2015. A systematic review and meta-analysis of brief versus ultrabrief right unilateral electroconvulsive therapy for depression. J Clin Psychiatry. 76:e1092–e1098.
  • Trevithick L, McAllister-Williams RH, Blamire A, Branton T, Clark R, Downey D, Dunn G, Easton A, Elliott R, Ellwell C, et al. 2015. Study protocol for the randomised controlled trial: ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study). BMC Psychiatry. 15:257.
  • Wang X, Chen Y, Zhou X, Liu F, Zhang T, Zhang C. 2012. Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder. J ECT. 28:128–132.
  • Xu Y, Hackett M, Carter G, Loo C, Gálvez V, Glozier N, Glue P, Lapidus K, McGirr A, Somogyi AA, et al. 2016. Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 19. pii:pyv124. doi: 10.1093/ijnp/pyv124.
  • Yalcin S, Aydogan H, Selek S, Kucuk A, Yuce HH, Karababa F, Bilgic T. 2012. Ketofol in electroconvulsive therapy anesthesia: two stones for one bird. J Anesth. 26:562–567.
  • Yen T, Khafaja M, Lam N, Crumbacher J, Schrader R, Rask J, Billstrand M, Rothfork J, Abbott CC. 2015. Post-electroconvulsive therapy recovery and reorientation time with methohexital and ketamine: a randomized, longitudinal, crossover design trial. J ECT. 31:20–25.
  • Yoosefi A, Sepehri AS, Kargar M, Akhondzadeh S, Sadeghi M, Rafei A, Alimadadi A, Ghaeli P. 2014. Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study. J ECT. 30:15–21.
  • Zhu X, Li P, Hao X, Wei K, Min S, Luo J, Xie F, Jin J. 2015. Ketamine-mediated alleviation of electroconvulsive shock-induced memory impairment is associated with the regulation of neuroinflammation and soluble amyloid-beta peptide in depressive-like rats. Neurosci Lett. 599:32–37.
  • Zhong X, He H, Zhang C, Wang Z, Jiang M, Li Q, Zhang M, Huang X. 2016. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression. J Affect Disord. 201:124–130.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.